Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Tue, 10th Mar 2015 15:56

UK Earnings, Trading Statements Calendar 
Wednesday, March 11 
Centaur MediaFull Year Results
N BrownTrading Statement
BWINFull Year Results
FoxtonsFull Year Results
Brooks MacdonaldHalf Year Results
FerrexpoFull Year Results
HikmaFull Year Results
Servelec GroupFull Year Results
Modern WaterFull Year Results
Michael Page InternationalFull Year Results
Ceres Power Holdings Half Year Results
FDM GroupFull Year Results
Boohoo.comTrading Statement
Thursday, March 12 
Cineworld GroupFull Year Results
LSL PropertyFull Year Results
Wm Morrison SupermarketsFull Year Results
ComputacenterTrading Statement
FennerTrading Statement
Home Retail GroupTrading Statement
SIGFull Year Results
TT ElectronicsFull Year Results
ASOSTrading Statement
Stock Spirits GroupFull Year Results
Cambridge Cognition HoldingsFull Year Results
SOCO InternationalFull Year Results
Secure Income REITFull Year Results 
Friday, March 13 
JD WetherspoonHalf Year Results
SthreeQ1 Interim Management Statement
Oxford BiomedicaFull Year Results
Independent News & MediaFull Year Results 
Monday, March 16 
Tribal GroupFull Year Results
Real Estate Investors Full Year Results
EKF Diagnostics HoldingsFull Year Results
BradyFull Year Results
Smart Metering SystemsFull Year Results
Petards GroupFull Year Results
Tuesday, March 17 
French Connection GroupFull Year Results
RegenersisHalf Year Results
AntofagastaFull Year Results
Mears GroupFull Year Results
IG GroupInterim Management Statement 
Fairpoint GroupFull Year Results
J SainsburyQ4 Trading Statement
WANdiscoFull Year Results
Just EatFull Year Results
SafeCharge International GroupFull Year Results
Onesavings BankFull Year Results
GfinityHalf Year Results
Good Energy GroupFull Year Results
KBC Advanced Technologies Full Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.
  

More News
14 Mar 2019 13:04

DIRECTOR DEALINGS: Hikma Pharmaceuticals Non-Executive Buys Shares

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said that Non-Executive Director Pamela Kirby purchased GBP23,790 in company stock on Thursday.Kirby bought 1,500 shares at a price of per

Read more
13 Mar 2019 17:22

LONDON MARKET CLOSE: Stocks End Higher Ahead Of No-Deal Brexit Vote

LONDON (Alliance News) - Stocks in London ended marginally higher on Wednesday, with Standard Life Aberdeen and BP helping keep the FTSE 100 above the 7,150 mark.Attention will now shift to the in

Read more
13 Mar 2019 14:16

DIRECTOR DEALINGS: Hikma Chair And Vice Chair Buy 20,000 Shares Each

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said that both its executive chair and executive vice chair bought a substantial number of shares on Wednesday.Executive Chair Said bought

Read more
13 Mar 2019 11:59

LONDON MARKET MIDDAY: Stocks Subdued, Pound Rises Ahead Of Brexit Vote

LONDON (Alliance News) - London stocks were trading broadly flat at midday on Wednesday, with the pound creeping higher ahead of this evening's vote in Westminster, when members of Parliament

Read more
13 Mar 2019 10:41

WINNERS & LOSERS SUMMARY: Avast CEO Departure Overshadows Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Standard

Read more
13 Mar 2019 09:00

TOP NEWS: Hikma Swings To Profit After Columbus Impairment Year Before

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Wednesday said it swung to a profit from a loss in 2018 due to good demand, new product launches, and a substantial impairment the year drug a

Read more
13 Mar 2019 08:56

Hikma Pharma profits jab higher

(Sharecast News) - Hikma Pharmaceuticals grew 2018 sales and profits much more than it had expected at the start of last year, but final numbers and guidance for 2019 from the speciality and generic drug maker were both a little short of upgraded market forecasts.

Read more
13 Mar 2019 07:50

LONDON MARKET PRE-OPEN: Standard Life Board Shake-Up; Morrisons Payout

LONDON (Alliance News) - Stock prices in London are set to open lower on Wednesday, while the pound was steady after UK Prime Minister Theresa May's latest defeat in Parliament over her Brexit

Read more
12 Mar 2019 14:55

Wednesday preview: WA votes in Parliament, Hikma Pharmaceuticals

(Sharecast News) - Investors may be facing heightened volatility on Wednesday, as financial markets digest the result of Parliament's vote on Theresa May's proposal for the UK's withdrawal agreement with the European Union.

Read more
12 Mar 2019 08:37

Hikma Appoints Former Ipsen And Eisai North American Boss To Board

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Tuesday announced the former head of the US businesses of Ipsen and Eisai will be joining as a non-executive director.Cynthia Schwalm a

Read more
6 Mar 2019 15:56

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 7 March Melrose IndustriesFull Year ResultsNMC HealthFull Year Year Year Year 8

Read more
6 Mar 2019 09:20

Tobacco stocks rise after FDA boss Gottlieb quits

(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.

Read more
29 Jan 2019 12:11

Hikma Pharmaceuticals Launches Cancer Treatment Mitomycin In US

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it has launched cancer treatment Mitomycin as an injection in the US.Mitomycin, administered in doses of either 20 or 40 a

Read more
29 Jan 2019 09:42

Hikma launches generic Mitomycin injection in US

(Sharecast News) - Hikma Pharmaceuticals announced on Tuesday that its Hikma Pharmaceuticals USA division, formerly known as West-Ward Pharmaceuticals, has launched Mitomycin for Injection, USP' at dosages of 20mg and 40mg.

Read more
10 Dec 2018 14:18

Hikma US launches generic version of Lundbeck's Onfi

(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Lundbeck's Onfi, which is used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients of two years and older.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.